China Biotech Services Holdings Limited (HKG:8037)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.670
+0.010 (1.52%)
Apr 29, 2026, 3:54 PM HKT
91.43%
Market Cap 653.74M
Revenue (ttm) 73.50M
Net Income (ttm) -68.78M
Shares Out 975.73M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 310,000
Average Volume 506,750
Open 0.660
Previous Close 0.660
Day's Range 0.650 - 0.690
52-Week Range 0.340 - 1.330
Beta -0.73
RSI 43.43
Earnings Date Mar 27, 2026

About HKG:8037

China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People’s Republic of China and Hong Kong. The company operates through Medical and Health Related Services, Immunotherapy, Pharmaceutical Products, Insurance Brokerage, BNCT, and Others segments. It also engages in the provision of tumor immune cell therapy and health management services; sale and distribution of health related and pharmaceutical products; insurance brokerage services; provision of boron n... [Read more]

Sector Healthcare
Founded 1996
Employees 135
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8037
Full Company Profile

Financial Performance

In 2025, HKG:8037's revenue was 73.50 million, an increase of 4.25% compared to the previous year's 70.51 million. Losses were -68.78 million, -65.29% less than in 2024.

Financial Statements

News

There is no news available yet.